Sort
15,273 grants matching “antimicrobial resistance”
Mechanisms of Mycobacterial DNA Repair and Mutagenesis
$549,818Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2018 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis
$549,818Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2019 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis
$549,818Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2015 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis
$549,818Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2017 · AI
Mechanisms of Mycobacterial DNA Repair and Mutagenesis
$549,818Michael Stephen Glickman · Sloan-Kettering Inst Can Research · R01 · FY2016 · AI
GRAM+ ANTIMICROBIALS TARGETED TO DNA POLYMERASE III
$549,815Glsynthesis, Inc. · R44 · FY2000 · AI
Training innate immunity: A new approach to the treatment of sepsis
$549,730David L. Williams · East Tennessee State University · R01 · FY2017 · GM
Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease
$549,479Octavio Alberto Gonzalez · University Of Kentucky · R01 · FY2023 · DE
Role of Notch-1/PLA2-IIA in oral dysbiosis, inflammation, and periodontal disease
$549,479Octavio Alberto Gonzalez · University Of Kentucky · R01 · FY2025 · DE
A "radical" approach to tuberculosis infection
$549,000Deborah T Hung · Broad Institute, Inc. · R33 · FY2017 · AI
M. tuberculosis MazF toxins: target identification and stress adaptation
$548,706Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R56 · FY2015 · AI
A novel regulator of Pseudomonas aeruginosa keratitis
$548,622Feng Lin · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · EY
A novel regulator of Pseudomonas aeruginosa keratitis
$548,620Feng Lin · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · EY
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$548,474Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2022 · AA
Subproject 1 Compounds and Strategies for Treating MRSA and VRE
$548,430Suzanne L. Walker · Massachusetts Eye And Ear Infirmary · P01 · FY2016 · AI
A rapid, automated system for bacteria profiling of intra-abdominal infections
$548,325Don L Devoe · Univ Of Maryland, College Park · R01 · FY2025 · AI
Integrated Antimicrobial Drug Discovery Scheme for Multidrug Resistant Bacteria
$548,309Zoltan N. Oltvai · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · AI
TASK C34: PILOT INFECTION MODEL IN PIG-TAILED MACAQUES: ASSESSMENT OF NEISSERIA GONORRHEA (GC) AND CHLAMYDIA TRACHOMATIS (CT) CO-INFECTION
$548,306Dorothy Patton · Bioqual, Inc. · N01 · FY2018 · AI
Virulence Regulation by the Mycobacterium tuberculosis Proteasome
$548,256Katerina Heran Darwin · New York University School Of Medicine · R56 · FY2019 · AI
Molecular Analysis of Pathogens in Otitis Media by PCR
$548,173Garth D. Ehrlich · Drexel University · R01 · FY2013 · DC
Co-opting Endogenous Pathogen Autolysins as Next Generation Antibiotics
$547,683Karl E Griswold · Dartmouth College · R01 · FY2019 · AI
Co-opting Endogenous Pathogen Autolysins as Next Generation Antibiotics
$547,683Karl E Griswold · Dartmouth College · R01 · FY2018 · AI
Co-opting Endogenous Pathogen Autolysins as Next Generation Antibiotics
$547,683Karl E Griswold · Dartmouth College · R01 · FY2020 · AI
Co-opting Endogenous Pathogen Autolysins as Next Generation Antibiotics
$547,683Karl E Griswold · Dartmouth College · R01 · FY2021 · AI
Targeting DXP synthase in bacterial metabolism
$547,594Caren L. Freel Meyers · Johns Hopkins University · R01 · FY2021 · AI